Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

Detected CMS Systems:

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. Social Networks
  11. External Links
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.616625/full, but it redirected us to https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.616625/full. The analysis below is for the second page.

Title[redir]:
Frontiers | Androgen Receptor, Although Not a Specific Marker For, Is a Novel Target to Suppress Glioma Stem Cells as a Therapeutic Strategy for Glioblastoma
Description:
Targeting androgen receptor (AR) has been shown to be promising in treating glioblastoma (GBM) in cell culture and flank implant models but the mechanisms re...

Matching Content Categories {📚}

  • Science
  • Education
  • Telecommunications

Content Management System {📝}

What CMS is doi.org built with?


Doi.org uses TYPESETTER CMS.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 91,705,781 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We can't tell how the site generates income.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Doi.org could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

cells, cell, gbm, cancer, enzalutamide, google, scholar, doi, text, abstract, crossref, full, pubmed, expression, tumor, treatment, stem, figure, brain, umg, androgen, prostate, staining, control, patients, lines, receptor, glioblastoma, usa, mice, nanog, results, genes, vitro, spheroids, mouse, antagonists, studies, levels, mgpp, csc, showed, cscs, significantly, human, glioma, proliferation, line, marker, vivo,

Topics {✒️}

constitutively active ar-splice-variant vsvg-pseudotyped pdgf-ires-cre c-terminal ligand-binding domain aromatase-mediated testosterone conversion/depletion crispr/cas9-mediated ar knockout apc-conjugated anti-cd133 antibody data availability statement fbxw7/c-myc axis castration-resistant prostate cancer tumor sphere-forming capacities tgf-β signaling pathway tumor sphere-forming stem rare long-term survivors castration-resistant prostate cancers ligand-activated transcription factors ethics statement nuclear-dominant expression patterns anchorage-dependent cell growth stop-floxed luciferase reporter quantitative rt-pcr assays gov/geo/query/acc tumor sphere-forming cells open-access article distributed sexually-dimorphic aromatase expression tgf-β signaling pathways monoclonal anti-c-myc fluorescence-activated cell sorting aggressive prostate cancer monoclonal anti-β-actin enzalutamide downregulates c-myc quantitative rt-pcr results androgen receptor-mediated inhibition high-throughput sequencing data polyclonal anti-ar antibody c-myc expression levels ar-positive cell line orthotopic mouse model monoclonal anti-oct4 antibody promoting cell cycling/proliferation oncogene c-myc expressions cell lines derived stem cell characteristics local ethical guidelines western blotting assays tumor spheroids/cell culture human brain/gbm tissue cancer stem cell tumor-initiating capability supplementary material variable expression levels

Questions {❓}

  • Do Steroid Hormones Play a Role in the Etiology of Glioma?

Schema {🗺️}

ScholarlyArticle:
      context:https://schema.org
      headline:Androgen Receptor, Although Not a Specific Marker For, Is a Novel Target to Suppress Glioma Stem Cells as a Therapeutic Strategy for Glioblastoma
      author:
            type:Person
            name:Nan Zhao
            affiliation:
               Department of Radiation Oncology, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, United States
            type:Person
            name:Fei Wang
            affiliation:
               Department of Radiation Oncology, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, United States
            type:Person
            name:Shaheen Ahmed
            affiliation:
               Department of Pharmaceutical Sciences, University of Nebraska Medical Center, United States
            type:Person
            name:Kan Liu
            affiliation:
               School of Biological Sciences, University of Nebraska—Lincoln, United States
            type:Person
            name:Chi Zhang
            affiliation:
               School of Biological Sciences, University of Nebraska—Lincoln, United States
            type:Person
            name:Sahara J. Cathcart
            affiliation:
               Department of Pathology and Microbiology, University of Nebraska Medical Center, United States
            type:Person
            name:Dominick J. DiMaio
            affiliation:
               Department of Pathology and Microbiology, University of Nebraska Medical Center, United States
            type:Person
            name:Michael Punsoni
            affiliation:
               Department of Pathology and Microbiology, University of Nebraska Medical Center, United States
            type:Person
            name:Bingjie Guan
            affiliation:
               Department of Radiation Oncology, Union Hospital of Fujian Medical University, China
            type:Person
            name:Ping Zhou
            affiliation:
               Department of Radiation Oncology, The First Affiliated Hospital of Hainan Medical University, China
            type:Person
            name:Shuo Wang
            affiliation:
               Department of Radiation Oncology, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, United States
            type:Person
            name:Surinder K. Batra
            affiliation:
               Department of Biochemistry and Molecular Biology, College of Medicine, Eppley Institute for Research in Cancer, University of Nebraska Medical Center, United States
            type:Person
            name:Tatiana Bronich
            affiliation:
               Department of Pharmaceutical Sciences, University of Nebraska Medical Center, United States
            type:Person
            name:Tom K. Hei
            affiliation:
               Center for Radiological Research, College of Physicians and Surgeons, Columbia University, United States
            type:Person
            name:Chi Lin
            affiliation:
               Department of Radiation Oncology, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, United States
            type:Person
            name:Chi Zhang
            affiliation:
               Department of Radiation Oncology, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, United States
      datePublished:2021-05-21
      dateModified:2025-07-01
      publisher:
         type:Organization
         name:Frontiers
      isPartOf:
         type:PublicationIssue
         datePublished:2021
         isPartOf:
            type:PublicationVolume
            volumeNumber:11
            isPartOf:
               type:Periodical
               name:Frontiers in Oncology
      citation:
         https://doi.org/10.3389/fonc.2021.616625
      inLanguage:en
Person:
      name:Nan Zhao
      affiliation:
         Department of Radiation Oncology, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, United States
      name:Fei Wang
      affiliation:
         Department of Radiation Oncology, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, United States
      name:Shaheen Ahmed
      affiliation:
         Department of Pharmaceutical Sciences, University of Nebraska Medical Center, United States
      name:Kan Liu
      affiliation:
         School of Biological Sciences, University of Nebraska—Lincoln, United States
      name:Chi Zhang
      affiliation:
         School of Biological Sciences, University of Nebraska—Lincoln, United States
      name:Sahara J. Cathcart
      affiliation:
         Department of Pathology and Microbiology, University of Nebraska Medical Center, United States
      name:Dominick J. DiMaio
      affiliation:
         Department of Pathology and Microbiology, University of Nebraska Medical Center, United States
      name:Michael Punsoni
      affiliation:
         Department of Pathology and Microbiology, University of Nebraska Medical Center, United States
      name:Bingjie Guan
      affiliation:
         Department of Radiation Oncology, Union Hospital of Fujian Medical University, China
      name:Ping Zhou
      affiliation:
         Department of Radiation Oncology, The First Affiliated Hospital of Hainan Medical University, China
      name:Shuo Wang
      affiliation:
         Department of Radiation Oncology, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, United States
      name:Surinder K. Batra
      affiliation:
         Department of Biochemistry and Molecular Biology, College of Medicine, Eppley Institute for Research in Cancer, University of Nebraska Medical Center, United States
      name:Tatiana Bronich
      affiliation:
         Department of Pharmaceutical Sciences, University of Nebraska Medical Center, United States
      name:Tom K. Hei
      affiliation:
         Center for Radiological Research, College of Physicians and Surgeons, Columbia University, United States
      name:Chi Lin
      affiliation:
         Department of Radiation Oncology, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, United States
      name:Chi Zhang
      affiliation:
         Department of Radiation Oncology, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, United States
Organization:
      name:Frontiers
PublicationIssue:
      datePublished:2021
      isPartOf:
         type:PublicationVolume
         volumeNumber:11
         isPartOf:
            type:Periodical
            name:Frontiers in Oncology
PublicationVolume:
      volumeNumber:11
      isPartOf:
         type:Periodical
         name:Frontiers in Oncology
Periodical:
      name:Frontiers in Oncology

Social Networks {👍}(7)

External Links {🔗}(385)

Libraries {📚}

  • Vue.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Cloudflare
  • Crossref

6.28s.